{
  "ticker": "NVO",
  "name": "Novo Nordisk A/S",
  "price": 50.88,
  "market_cap": 226084241408,
  "revenue_ttm": 49695312057.13962,
  "net_income_ttm": 16340249041.059652,
  "ocf_ttm": 19491210500.790455,
  "capex_ttm": 9893933954.361368,
  "sbc_ttm": 0.0,
  "buyback_ttm": 1398100384.8358307,
  "total_debt": 15937305141.43189,
  "cash_and_equivalents": 5130567050.2428055,
  "book_value_ttm": 26752073767.54908,
  "shares_outstanding": 3368607341,
  "beta": 1.2,
  "roe": 71.47,
  "analyst_growth_estimate": 5.1,
  "forward_eps": 3.4471674,
  "dividend_yield": 339.0,
  "sector_type": "BioTech",
  "currency_code": "USD",
  "last_updated": "2026-01-02T01:28:01Z"
}